论文信息 - Treatment with FLT3 inhibitor in patients with FLT3‐mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations - 字舞流文

Treatment with FLT3 inhibitor in patients with FLT3‐mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations

M. Konopleva | Z. Estrov | M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | F. Ravandi | G. Borthakur | R. Luthra | Y. Alvarado